These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin. Dallman PR Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712 [No Abstract] [Full Text] [Related]
6. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants. Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy. Harris SA; Payne G; Putman JM Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097 [TBL] [Abstract][Full Text] [Related]
8. [Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants]. Rabbani F Lik Sprava; 2002; (3-4):81-4. PubMed ID: 12145901 [TBL] [Abstract][Full Text] [Related]
9. Use of epoetin (erythropoietin) in the anemia of prematurity. Novick D; Moore TB; Feig SA West J Med; 1995 Apr; 162(4):355-6. PubMed ID: 7747503 [No Abstract] [Full Text] [Related]
10. Erythropoietin in obstetrics. Huch R; Huch A Hematol Oncol Clin North Am; 1994 Oct; 8(5):1021-40. PubMed ID: 7852210 [TBL] [Abstract][Full Text] [Related]
11. Recombinant erythropoietin in very-low-birth-weight infants. Carnielli VP; Da Riol R; Montini G N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8052282 [No Abstract] [Full Text] [Related]
12. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma]. Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590 [No Abstract] [Full Text] [Related]
13. Recombinant erythropoietin in very-low-birth-weight infants. Beck D; Calame A; Masserey E N Engl J Med; 1994 Sep; 331(10):676-7; author reply 677-8. PubMed ID: 8052281 [No Abstract] [Full Text] [Related]
14. Recombinant erythropoietin in very-low-birth-weight infants. van den Anker JN; Montini G; Carnielli VP N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8093178 [No Abstract] [Full Text] [Related]
15. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes. Laporte JP; Isnard F; Fenaux P; Woler M; Najman A Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189 [No Abstract] [Full Text] [Related]
16. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients]. Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694 [No Abstract] [Full Text] [Related]
18. Erythropoietin to prevent transfusions in premature infants. Alfaleh K; Thabane L J Perinatol; 2005 Aug; 25(8):560. PubMed ID: 16047037 [No Abstract] [Full Text] [Related]
19. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity". Christensen RD Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299 [No Abstract] [Full Text] [Related]
20. Financial impact of the introduction of erythropoietin in the treatment of anemia of premature infants in Israel. Dollberg S; Mimouni FB Isr Med Assoc J; 1999 Oct; 1(2):86-8. PubMed ID: 10731302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]